Abstract

As advances in genomics and in vitro fertilization unite to bring us such technologies as germline manipulation and in‐depth embryo diagnosis, must there be a battle over their use? Policymakers might, after all, acknowledge the arrival of these technologies, accept that people differ in their attitudes toward them, realize that society will adjust as it has to past advances such as the birth‐control pill, and support efforts to minimize risks and maximize benefits. Unfortunately, that scenario is unlikely.